Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study

Sebastiano Bucello; Pietro Annovazzi; Paolo Ragonese; Marta Altieri; Valeria Barcella; Roberto Bergamaschi; Alessia Bianchi; Giovanna Borriello; Maria Chiara Buscarinu; Graziella Callari; Marco Capobianco; Fioravante Capone; Paola Cavalla; Rosella Cavarretta; Antonio Cortese; Giovanna De Luca; Massimiliano Di Filippo; Vincenzo Dattola; Roberta Fantozzi; Elisabetta Ferraro; Maria Maddalena Filippi; Claudio Gasperini; Luigi Maria Edoardo Grimaldi; Doriana Landi; Marianna Lo Re; Giulia Mallucci; Paolo Manganotti; Girolama Alessandra Marfia; Massimiliano Mirabella; Paola Perini; Marco Pisa; Sabrina Realmuto; Margherita Russo; Valentina Tomassini; Valentina Torri Clerici; Mauro Zaffaroni; Cristina Zuliani; Sofia Zywicki; Massimo Filippi; Luca Prosperini

doi:10.1007/s00415-021-10455-3

Related publications

Article2022

Real world comparison of teriflunomide and dimethyl fumarate in naïve relapsing multiple sclerosis patients: Evidence from the Italian MS register

Aurora Zanghì, Carlo Avolio, Maria Pia Amato, Massimo Filippi, María Trojano, Francesco Patti, Emanuele D’ Amico

Preprint2020

COVID-19 in Teriflunomide-Treated Patients with Multiple Sclerosis

Amir‐Hadi Maghzi, Maria K. Houtchens, Paolo Preziosa, Carolina Ionete, Biljana Beretich, James Stankiewicz, Shahamat Tauhid, Ann Cabot, Idanis Berriosmorales, Tamara HW Schwartz, Jacob A. Sloane, Mark S. Freedman, Massimo Filippi, Howard L. Weiner, Rohit Bakshi

Article2020

COVID-19 in teriflunomide-treated patients with multiple sclerosis

Amir Hadi Maghzi, Maria K. Houtchens, Paolo Preziosa, Carolina Ionete, Biljana Beretich, James Stankiewicz, Shahamat Tauhid, Ann Cabot, Idanis Berriosmorales, Tamara Schwartz, Jacob A. Sloane, Mark S. Freedman, Massimo Filippi, Howard L. Weiner, Rohit Bakshi

Article2021

Italian multicenter observational study on real-life experience with alemtuzumab in naïve patients with aggressive multiple sclerosis

Lucia Moiola, Chiara Zanetta, Maria Di Cristinzi, Agostino Nozzolillo, Francesca Rinaldi, Laura Brambilla, Pietro Annovazzi, Giacomo Lus, Giorgia Puorro, Jessica Frau, Simona Malucchi, Assunta Bianco, Caterina Lapucci, Girolama Alessandra Marfia, Antonio Gallo, Raffaella Cerqua, Paola Cavalla, Massimo Filippi

Article2023

Ocrelizumab extended‐interval dosing in multiple sclerosis during <scp>SARS‐CoV</scp>‐2 pandemic: a real‐world experience

Simone Guerrieri, Chiara Bucca, Agostino Nozzolillo, Angela Genchi, Chiara Zanetta, Ilaria Cetta, Giulia Rugarli, Irene Gattuso, Matteo Azzimonti, Maria A. Rocca, Lucia Moiola, Massimo Filippi